エピネフリンのグローバル及び中国市場 2027年

【英語タイトル】Global and China Epinephrine Market Insights, Forecast to 2027

QYResearchが出版した調査資料(QY21CN3776)・商品コード:QY21CN3776
・発行会社(調査会社):QYResearch
・発行日:2021年7月6日(※2023年版があります。お問い合わせください。)
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(24時間以内)
・調査対象地域:グローバル、中国
・産業分野:医療装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥507,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥760,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,014,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートではグローバルにおけるエピネフリンの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、エピネフリンの種類別市場規模(エピネフリン自動注射器、エピネフリンプレフィルドシリンジ、混合エピネフリン製品)、用途別市場規模(アナフィラキシー、心停止、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のエピネフリン市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるエピネフリンの種類別市場規模(2016年-2027年):エピネフリン自動注射器、エピネフリンプレフィルドシリンジ、混合エピネフリン製品
・世界におけるエピネフリンの用途別市場規模(2016年-2027年):アナフィラキシー、心停止、その他
・エピネフリンの中国市場分析
- エピネフリンの中国市場規模(2016年-2027年)
- 中国におけるエピネフリンの主要プレイヤー別市場シェア
- 中国におけるエピネフリンの種類別市場規模:エピネフリン自動注射器、エピネフリンプレフィルドシリンジ、混合エピネフリン製品
- 中国におけるエピネフリンの用途別市場規模:アナフィラキシー、心停止、その他
・エピネフリンの北米市場(2016年-2027年)
・エピネフリンのヨーロッパ市場(2016年-2027年)
・エピネフリンのアジア太平洋市場(2016年-2027年)
・エピネフリンの中南米市場(2016年-2027年)
・エピネフリンの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Mylan Inc、Impax、ALK Abello、Lincoln Medical、Pfizer、Amphastar、Emerade、Grand Pharma、Harvest Pharmaceuticals、Merit Pharmaceutical、Tianjin Jinyao
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...
❖ レポートの概要 ❖

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.
Global Epinephrine key players include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, etc. Global top five manufacturers hold a share about 60%. USA is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Epinephrine Auto-injector is the largest segment, with a share about 60%. And in terms of application, the largest application is Anaphylaxis, followed by Cardiac Arrest, etc.

Market Analysis and Insights: Global and China Epinephrine Market
This report focuses on global and China Epinephrine market.
In 2020, the global Epinephrine market size was US$ 2835 million and it is expected to reach US$ 4583.3 million by the end of 2027, with a CAGR of 7.1% during 2021-2027. In China the Epinephrine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Epinephrine Scope and Market Size
Epinephrine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Epinephrine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Epinephrine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products

Segment by Application
Anaphylaxis
Cardiac Arrest
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Mylan Inc
Impax
ALK Abello
Lincoln Medical
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao

❖ レポートの目次 ❖

1 Study Coverage
1.1 Epinephrine Product Introduction
1.2 Market by Type
1.2.1 Global Epinephrine Market Size Growth Rate by Type
1.2.2 Epinephrine Auto-injector
1.2.3 Epinephrine Prefilled Syringe
1.2.4 Combination Epinephrine Products
1.3 Market by Application
1.3.1 Global Epinephrine Market Size Growth Rate by Application
1.3.2 Anaphylaxis
1.3.3 Cardiac Arrest
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Epinephrine Market Size, Estimates and Forecasts
2.1.1 Global Epinephrine Revenue 2016-2027
2.1.2 Global Epinephrine Sales 2016-2027
2.2 Global Epinephrine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Epinephrine Historical Market Size by Region (2016-2021)
2.3.1 Global Epinephrine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Epinephrine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Epinephrine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Epinephrine Sales Forecast by Region (2022-2027)
2.4.2 Global Epinephrine Revenue Forecast by Region (2022-2027)

3 Global Epinephrine Competitor Landscape by Players
3.1 Global Top Epinephrine Manufacturers by Sales
3.1.1 Global Epinephrine Sales by Manufacturer (2016-2021)
3.1.2 Global Epinephrine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Epinephrine Manufacturers by Revenue
3.2.1 Key Epinephrine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Epinephrine Revenue by Manufacturers (2016-2021)
3.2.3 Global Epinephrine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Epinephrine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Epinephrine Revenue in 2020
3.2.6 Global Epinephrine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Epinephrine Price by Manufacturers
3.4 Global Epinephrine Manufacturing Base Distribution, Product Types
3.4.1 Epinephrine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Epinephrine Product Type
3.4.3 Date of International Manufacturers Enter into Epinephrine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Epinephrine Market Size by Type (2016-2021)
4.1.1 Global Epinephrine Sales by Type (2016-2021)
4.1.2 Global Epinephrine Revenue by Type (2016-2021)
4.1.3 Epinephrine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Epinephrine Market Size Forecast by Type (2022-2027)
4.2.1 Global Epinephrine Sales Forecast by Type (2022-2027)
4.2.2 Global Epinephrine Revenue Forecast by Type (2022-2027)
4.2.3 Epinephrine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Epinephrine Market Size by Application (2016-2021)
5.1.1 Global Epinephrine Sales by Application (2016-2021)
5.1.2 Global Epinephrine Revenue by Application (2016-2021)
5.1.3 Epinephrine Price by Application (2016-2021)
5.2 Epinephrine Market Size Forecast by Application (2022-2027)
5.2.1 Global Epinephrine Sales Forecast by Application (2022-2027)
5.2.2 Global Epinephrine Revenue Forecast by Application (2022-2027)
5.2.3 Global Epinephrine Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Epinephrine Market Size YoY Growth 2016-2027
6.1.1 China Epinephrine Sales YoY Growth 2016-2027
6.1.2 China Epinephrine Revenue YoY Growth 2016-2027
6.1.3 China Epinephrine Market Share in Global Market 2016-2027
6.2 China Epinephrine Market Size by Players (International and Local Players)
6.2.1 China Top Epinephrine Players by Sales (2016-2021)
6.2.2 China Top Epinephrine Players by Revenue (2016-2021)
6.3 China Epinephrine Historic Market Review by Type (2016-2021)
6.3.1 China Epinephrine Sales Market Share by Type (2016-2021)
6.3.2 China Epinephrine Revenue Market Share by Type (2016-2021)
6.3.3 China Epinephrine Price by Type (2016-2021)
6.4 China Epinephrine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Epinephrine Sales Forecast by Type (2022-2027)
6.4.2 China Epinephrine Revenue Forecast by Type (2022-2027)
6.4.3 China Epinephrine Price Forecast by Type (2022-2027)
6.5 China Epinephrine Historic Market Review by Application (2016-2021)
6.5.1 China Epinephrine Sales Market Share by Application (2016-2021)
6.5.2 China Epinephrine Revenue Market Share by Application (2016-2021)
6.5.3 China Epinephrine Price by Application (2016-2021)
6.6 China Epinephrine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Epinephrine Sales Forecast by Application (2022-2027)
6.6.2 China Epinephrine Revenue Forecast by Application (2022-2027)
6.6.3 China Epinephrine Price Forecast by Application (2022-2027)

7 North America
7.1 North America Epinephrine Market Size YoY Growth 2016-2027
7.2 North America Epinephrine Market Facts & Figures by Country
7.2.1 North America Epinephrine Sales by Country (2016-2021)
7.2.2 North America Epinephrine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Epinephrine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Epinephrine Market Facts & Figures by Region
8.2.1 Asia Pacific Epinephrine Sales by Region (2016-2021)
8.2.2 Asia Pacific Epinephrine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Epinephrine Market Size YoY Growth 2016-2027
9.2 Europe Epinephrine Market Facts & Figures by Country
9.2.1 Europe Epinephrine Sales by Country (2016-2021)
9.2.2 Europe Epinephrine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Epinephrine Market Size YoY Growth 2016-2027
10.2 Latin America Epinephrine Market Facts & Figures by Country
10.2.1 Latin America Epinephrine Sales by Country (2016-2021)
10.2.2 Latin America Epinephrine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Epinephrine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Epinephrine Market Facts & Figures by Country
11.2.1 Middle East and Africa Epinephrine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Epinephrine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Mylan Inc
12.1.1 Mylan Inc Corporation Information
12.1.2 Mylan Inc Description and Business Overview
12.1.3 Mylan Inc Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Mylan Inc Epinephrine Products Offered
12.1.5 Mylan Inc Recent Development
12.2 Impax
12.2.1 Impax Corporation Information
12.2.2 Impax Description and Business Overview
12.2.3 Impax Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Impax Epinephrine Products Offered
12.2.5 Impax Recent Development
12.3 ALK Abello
12.3.1 ALK Abello Corporation Information
12.3.2 ALK Abello Description and Business Overview
12.3.3 ALK Abello Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ALK Abello Epinephrine Products Offered
12.3.5 ALK Abello Recent Development
12.4 Lincoln Medical
12.4.1 Lincoln Medical Corporation Information
12.4.2 Lincoln Medical Description and Business Overview
12.4.3 Lincoln Medical Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lincoln Medical Epinephrine Products Offered
12.4.5 Lincoln Medical Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Epinephrine Products Offered
12.5.5 Pfizer Recent Development
12.6 Amphastar
12.6.1 Amphastar Corporation Information
12.6.2 Amphastar Description and Business Overview
12.6.3 Amphastar Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amphastar Epinephrine Products Offered
12.6.5 Amphastar Recent Development
12.7 Emerade
12.7.1 Emerade Corporation Information
12.7.2 Emerade Description and Business Overview
12.7.3 Emerade Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Emerade Epinephrine Products Offered
12.7.5 Emerade Recent Development
12.8 Grand Pharma
12.8.1 Grand Pharma Corporation Information
12.8.2 Grand Pharma Description and Business Overview
12.8.3 Grand Pharma Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Grand Pharma Epinephrine Products Offered
12.8.5 Grand Pharma Recent Development
12.9 Harvest Pharmaceuticals
12.9.1 Harvest Pharmaceuticals Corporation Information
12.9.2 Harvest Pharmaceuticals Description and Business Overview
12.9.3 Harvest Pharmaceuticals Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Harvest Pharmaceuticals Epinephrine Products Offered
12.9.5 Harvest Pharmaceuticals Recent Development
12.10 Merit Pharmaceutical
12.10.1 Merit Pharmaceutical Corporation Information
12.10.2 Merit Pharmaceutical Description and Business Overview
12.10.3 Merit Pharmaceutical Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merit Pharmaceutical Epinephrine Products Offered
12.10.5 Merit Pharmaceutical Recent Development
12.11 Mylan Inc
12.11.1 Mylan Inc Corporation Information
12.11.2 Mylan Inc Description and Business Overview
12.11.3 Mylan Inc Epinephrine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Mylan Inc Epinephrine Products Offered
12.11.5 Mylan Inc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Epinephrine Industry Trends
13.2 Epinephrine Market Drivers
13.3 Epinephrine Market Challenges
13.4 Epinephrine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Epinephrine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 掲載企業 ❖

Mylan Inc、Impax、ALK Abello、Lincoln Medical、Pfizer、Amphastar、Emerade、Grand Pharma、Harvest Pharmaceuticals、Merit Pharmaceutical、Tianjin Jinyao

★調査レポート[エピネフリンのグローバル及び中国市場 2027年] (コード:QY21CN3776)販売に関する免責事項を必ずご確認ください。
★調査レポート[エピネフリンのグローバル及び中国市場 2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆